Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
NCT04748601
This study is recruiting at 6 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Migraine Disorders
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 6 to 11 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Upsher-Smith Laboratories
- Last updated on ClinicalTrials.gov
- January 27, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Upsher-Smith Clinical Trial Site #15 · La Jolla, CA
Florida · 1
- Upsher-Smith Clinical Trial Site #14 · Tampa, FL
Ohio · 1
- Upsher-Smith Clinical Trial Site #4 · Cincinnati, OH
Oregon · 2
- Upsher-Smith Clinical Trial Site #6 · Portland, OR
- Upsher-Smith Clinical Trials Site #7 · Springfield, OR
West Virginia · 1
- Upsher-Smith Clinical Trial Site #9 · Huntington, WV
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.